Monocyte activation after open and laparoscopic surgery

British Journal of Surgery

Volumn 84, Issue 8, 1997, Pages 1152-1156

  Klava, A ^a   Windsor, A ^a   Boylston, A W ^a   Reynolds, J V ^a   Ramsden, C W ^a   Guillou, P J ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BIOLOGICAL RESPONSE MODIFIER; GAMMA INTERFERON; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ABDOMINAL SURGERY; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; SEPSIS; SURGICAL INJURY;

ADULT; AGED; AGED, 80 AND OVER; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; INTERFERON-GAMMA, RECOMBINANT; LAPAROSCOPY; LEUKOCYTE COUNT; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONOCYTES; POSTOPERATIVE PERIOD; SURGICAL PROCEDURES, ELECTIVE; SURGICAL PROCEDURES, OPERATIVE;

EID: 0030796939     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800840832     Document Type: Article

References (21)

1. Guillou PJ. Biological variation in the development of sepsis after surgery or trauma. Lancet 1993; 342: 217-20.
2. Lennard TWJ, Shenton BK, Borzotta A et al. The influence of surgical operations on components of the human immune system. Br J Surg 1985; 72: 771-6.
3. Meakins JL, Pietsch JB, Bubenick O et al. Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma. Ann Surg 1977; 186: 241-50.
4. Polk HC Jr. Non-specific host defence stimulation in the reduction of surgical infection in man. Br J Surg 1987; 74: 969-70 (Editorial).
5. Polk HC, George CD, Hershman MJ, Wellhausen SR, Cheadle WG. The capacity of serum to support neutrophil phagocytosis is a vital host defense mechanism in severely injured patients. Ann Surg 1988; 207: 686-92.
6. Hershman MJ, Cheadle WG, Wellhausen SR, Davidson PF, Polk HC Jr. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 1990; 77: 204-7.
7. Wakefield CH, Carey PD, Foulds S, Monson JRT, Guillou PJ. Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg 1993; 80: 205-9.
8. Hershman MJ, Appel SH, Wellhausen SR, Sonnenfeld G, Polk HC Jr. Interferon-gamma treatment increases HLA-DR expression on monocytes in severely injured patients. Clin Exp Immunol 1989; 77: 67-70.
9. Polk HC Jr, Cheadle WG, Livingston DH et al. A randomized prospective trial to determine the efficacy of interferon-gamma in severely injured patients. Am J Surg 1992; 163: 191-6.
10. Dries DJ, Jurkovich GJ, Maier RV et al. Effect of interferon gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial. Arch Surg 1994; 129: 1031-41.
11. Carey PD, Wakefield CH, Thayeb A, Monson JR, Darzi A, Guillou PJ. Effects of minimally invasive surgery on hypochlorous acid production by neutrophils. Br J Surg 1994; 81: 557-60.
12. Redmond HP, Watson RW, Houghton T, Condron C, Watson RGK, Bouchier-Hayes D. Immune function in patients undergoing open vs laparoscopic cholecystectomy. Arch Surg 1994; 129: 1240-6.
13. Cheadle WG, Hershman MJ, Wellhausen SR, Polk HC Jr. HLA-DR antigen expression on peripheral blood monocytes correlates with surgical infection. Am J Surg 1991; 161: 639-45.
14. Gibbons RA, Martinez OM, Lim RC, Horn JK, Garovoy MR. Reduction in HLA-DR, HLA-DQ and HLA-DP expression by Leu-M3+ cells from the peripheral blood of patients with thermal injury. Clin Exp Immunol 1989; 75: 371-5.
15. Hershman MJ, Cheadle WG, Kuftinec D, Polk HC Jr, George CD. An outcome predictive score for sepsis and death following injury. Injury 1988; 19: 263-6.
16. Babineau TJ, Hackford A, Kenler A et al. Phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients. Arch Surg 1994; 129: 1204-10.
17. Appel SH, Wellhausen SR, Montgomery R, DeWeese RC, Polk HC Jr. Experimental and clinical significance of endotoxin-dependent HLA-DR expression on monocytes. J Surg Res 1989; 47: 39-44.
18. Wakefield CW, Carey PD, Foulds S, Monson JRT, Guillou PJ. Surgery and the release of a neutrophil Fcγ receptor. Am J Surg 1995; 170: 277-84.
19. Klava A, Windsor AC, Boylston AC, Reynolds JV, Guillou PJ. Changes in CD14-positive monocyte subpopulations following surgery. Br J Surg 1995; 82: 1562 (Abstract).
20. Klava A, Woodhouse LF, Windsor A, Reynolds JV, Farmery SM, Guillou PJ. Interleukin 10 inhibits endotoxin-induced monocyte major histocompatibility complex class II upregulation after surgery. Br J Surg 1996; 83: 688 (Abstract).
21. Guillou PJ. Adjuvant biological response modifiers after major surgery or trauma. Br J Surg 1995; 85: 721-3.